Nifty

:

22795.90

Sensex

:

75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Login

Nifty
Sensex

:
:

22795.90
75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Medicamen Biotech Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 531146 | NSE: MEDICAMEQ

Watchlist

NSE BSE

525.00

06-Feb-2025

Open
High
Low
Previous Close

530.00
544.90
513.35
532.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

24281
129.33
630.00
355.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

695.81
82.74
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

709.56
0.18%
3.28

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.28
7.40
15.81

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.38
3.85
-0.48

PAT CAGR (%)

10 Years
5 Years
3 Years

40.62
-6.51
-13.96

P:E (Median)

8 Years
5 Years
3 Years

58.08
58.08
60.04

P:BV (Average)

8 Years
5 Years
3 Years

4.87
4.87
4.60

EV:EBITDA (Average)

8 Years
5 Years
3 Years

33.35
33.35
33.15

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 41.14 44.20 -6.92% 42.84 42.67 0.40% 41.48 40.50 2.42% 45.01 37.15 21.16%
Expenses 34.90 38.62 -9.63% 36.30 36.52 -0.60% 36.62 33.09 10.67% 38.19 30.38 25.71%
EBITDA 6.24 5.58 11.83% 6.55 6.15 6.50% 4.86 7.41 -34.41% 6.82 6.77 0.74%
EBIDTM 15.17% 12.63% 15.29% 14.42% 11.72% 18.30% 15.16% 18.22%
Other Income 0.14 0.83 -83.13% 0.29 0.55 -47.27% 0.57 0.38 50.00% 0.54 0.35 54.29%
Interest 0.73 0.65 12.31% 1.01 0.91 10.99% 0.68 0.96 -29.17% 1.87 0.86 117.44%
Depreciation 2.17 1.76 23.30% 2.57 1.80 42.78% 1.74 1.68 3.57% 1.77 1.61 9.94%
PBT 3.48 4.01 -13.22% 3.25 4.00 -18.75% 3.01 5.15 -41.55% 3.73 4.65 -19.78%
Tax 0.96 1.24 -22.58% 0.99 0.99 0.00% 0.76 0.74 2.70% 0.62 0.60 3.33%
PAT 2.52 2.77 -9.03% 2.27 3.01 -24.58% 2.26 4.42 -48.87% 3.10 4.05 -23.46%
PATM 6.13% 6.26% 5.30% 7.06% 5.44% 10.91% 6.89% 10.89%
EPS 1.99 2.18 -8.72% 1.79 2.37 -24.47% 1.78 3.48 -48.85% 2.44 3.19 -23.51%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 45.14 46.50 -2.92% 44.74 43.54 2.76% 43.05 41.94 2.65% 47.32 38.66 22.40%
Expenses 38.44 41.61 -7.62% 39.43 38.90 1.36% 39.60 34.99 13.18% 41.57 32.17 29.22%
EBITDA 6.71 4.89 37.22% 5.32 4.65 14.41% 3.45 6.95 -50.36% 5.75 6.49 -11.40%
EBIDTM 14.86% 10.52% 11.88% 10.67% 8.00% 16.57% 12.16% 16.79%
Other Income 0.14 0.83 -83.13% 0.29 0.55 -47.27% 0.59 0.38 55.26% 0.57 0.35 62.86%
Interest 0.76 0.65 16.92% 1.04 0.91 14.29% 0.71 0.96 -26.04% 1.89 0.86 119.77%
Depreciation 2.21 1.81 22.10% 2.61 1.82 43.41% 1.77 1.69 4.73% 1.77 1.62 9.26%
PBT 3.88 3.27 18.65% 1.96 2.46 -20.33% 1.56 4.68 -66.67% 2.66 4.36 -38.99%
Tax 0.96 1.24 -22.58% 1.05 0.99 6.06% 0.76 0.74 2.70% 0.62 0.59 5.08%
PAT 2.92 2.03 43.84% 0.91 1.48 -38.51% 0.80 3.95 -79.75% 2.04 3.77 -45.89%
PATM 6.47% 4.37% 2.02% 3.39% 1.85% 9.41% 4.32% 9.75%
EPS 2.73 1.60 70.62% 1.15 1.17 -1.71% 1.06 3.30 -67.88% 1.67 3.07 -45.60%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 170.47 172.39 137.88 115.45 110.15 117.34 122.60 111.51 82.46 67.28 77.79 Net Sales Growth 3.62% 25.03% 19.43% 4.81% -6.13% -4.29% 9.95% 35.23% 22.56% -13.51% Cost Of Goods Sold 92.90 71.96 52.66 43.51 47.48 59.66 69.26 49.05 37.50 29.05 37.26 Gross Profit 77.57 100.43 85.22 71.93 62.67 57.69 53.34 62.46 44.96 38.23 40.53 GP Margin 45.50% 58.26% 61.81% 62.30% 56.90% 49.16% 43.51% 56.01% 54.52% 56.82% 52.10% Total Expenditure 146.01 145.15 113.27 91.35 90.12 99.22 105.14 94.73 70.87 61.75 72.75 Power & Fuel Cost - 7.12 5.67 5.86 2.68 2.90 2.11 2.78 2.35 2.76 3.29 % Of Sales - 4.13% 4.11% 5.08% 2.43% 2.47% 1.72% 2.49% 2.85% 4.10% 4.23% Employee Cost - 22.12 18.57 14.50 8.79 9.29 8.09 9.05 6.65 4.86 5.42 % Of Sales - 12.83% 13.47% 12.56% 7.98% 7.92% 6.60% 8.12% 8.06% 7.22% 6.97% Manufacturing Exp. - 29.32 27.11 18.12 26.48 21.99 19.85 26.99 16.76 17.05 17.69 % Of Sales - 17.01% 19.66% 15.70% 24.04% 18.74% 16.19% 24.20% 20.33% 25.34% 22.74% General & Admin Exp. - 6.90 5.19 4.92 2.63 3.61 3.29 3.74 4.77 3.56 3.68 % Of Sales - 4.00% 3.76% 4.26% 2.39% 3.08% 2.68% 3.35% 5.78% 5.29% 4.73% Selling & Distn. Exp. - 6.48 2.92 3.36 1.71 1.45 2.33 3.11 2.84 3.92 4.46 % Of Sales - 3.76% 2.12% 2.91% 1.55% 1.24% 1.90% 2.79% 3.44% 5.83% 5.73% Miscellaneous Exp. - 1.25 1.16 1.07 0.34 0.32 0.22 0.01 0.01 0.55 4.46 % Of Sales - 0.73% 0.84% 0.93% 0.31% 0.27% 0.18% 0.01% 0.01% 0.82% 1.23% EBITDA 24.47 27.24 24.61 24.10 20.03 18.12 17.46 16.78 11.59 5.53 5.04 EBITDA Margin 14.35% 15.80% 17.85% 20.87% 18.18% 15.44% 14.24% 15.05% 14.06% 8.22% 6.48% Other Income 1.54 2.31 2.46 1.72 0.75 1.91 3.66 1.89 0.31 0.70 1.10 Interest 4.29 5.65 3.39 1.94 1.51 0.93 1.38 2.71 3.61 3.62 3.92 Depreciation 8.25 7.01 6.35 5.77 2.52 2.50 2.21 2.06 1.92 1.90 2.10 PBT 13.47 16.89 17.33 18.10 16.75 16.60 17.52 13.90 6.36 0.71 0.12 Tax 3.33 3.59 2.33 3.20 4.26 4.34 5.50 3.79 1.20 0.23 -0.32 Tax Rate 24.72% 21.26% 13.44% 17.68% 25.43% 26.14% 31.39% 27.27% 18.87% 32.39% -266.67% PAT 10.15 13.30 15.00 14.91 12.49 12.26 12.03 10.11 5.16 0.48 0.44 PAT before Minority Interest 10.15 13.30 15.00 14.91 12.49 12.26 12.03 10.11 5.16 0.48 0.44 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.95% 7.72% 10.88% 12.91% 11.34% 10.45% 9.81% 9.07% 6.26% 0.71% 0.57% PAT Growth -28.77% -11.33% 0.60% 19.38% 1.88% 1.91% 18.99% 95.93% 975.00% 9.09% EPS 7.99 10.47 11.81 11.74 9.83 9.65 9.47 7.96 4.06 0.38 0.35

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 180.25 179.31 140.87 115.45 112.72 125.50 122.60 Net Sales Growth 5.63% 27.29% 22.02% 2.42% -10.18% 2.37% Cost Of Goods Sold 94.44 73.18 53.25 43.51 50.06 65.62 69.26 Gross Profit 85.81 106.13 87.62 71.93 62.65 59.89 53.34 GP Margin 47.60% 59.19% 62.20% 62.30% 55.58% 47.72% 43.51% Total Expenditure 159.04 155.79 116.53 91.36 93.04 106.03 105.14 Power & Fuel Cost - 7.14 5.67 5.86 2.68 2.90 2.11 % Of Sales - 3.98% 4.02% 5.08% 2.38% 2.31% 1.72% Employee Cost - 29.07 20.15 14.50 9.00 9.52 8.09 % Of Sales - 16.21% 14.30% 12.56% 7.98% 7.59% 6.60% Manufacturing Exp. - 29.33 27.14 18.12 26.48 21.99 19.85 % Of Sales - 16.36% 19.27% 15.70% 23.49% 17.52% 16.19% General & Admin Exp. - 8.58 5.67 4.93 2.76 3.92 3.29 % Of Sales - 4.79% 4.02% 4.27% 2.45% 3.12% 2.68% Selling & Distn. Exp. - 7.27 3.48 3.36 1.71 1.77 2.33 % Of Sales - 4.05% 2.47% 2.91% 1.52% 1.41% 1.90% Miscellaneous Exp. - 1.23 1.18 1.07 0.34 0.32 0.22 % Of Sales - 0.69% 0.84% 0.93% 0.30% 0.25% 0.18% EBITDA 21.23 23.52 24.34 24.09 19.68 19.47 17.46 EBITDA Margin 11.78% 13.12% 17.28% 20.87% 17.46% 15.51% 14.24% Other Income 1.59 2.33 2.46 1.72 0.75 1.94 3.66 Interest 4.40 5.67 3.39 1.94 1.51 0.93 1.38 Depreciation 8.36 7.09 6.37 5.77 2.52 2.50 2.21 PBT 10.06 13.08 17.05 18.09 16.39 17.98 17.52 Tax 3.39 3.58 2.32 3.20 4.26 4.69 5.50 Tax Rate 33.70% 27.37% 13.61% 17.69% 25.99% 26.08% 31.39% PAT 6.67 9.49 14.73 14.90 12.13 13.29 12.03 PAT before Minority Interest 8.41 9.49 14.73 14.90 12.13 13.29 12.03 Minority Interest 1.74 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.70% 5.29% 10.46% 12.91% 10.76% 10.59% 9.81% PAT Growth -40.61% -35.57% -1.14% 22.84% -8.73% 10.47% EPS 5.25 7.47 11.60 11.73 9.55 10.46 9.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 209.21 193.80 148.04 134.35 122.48 86.63 74.61 26.78 17.91 17.18 Share Capital 12.71 12.65 12.22 12.22 12.22 11.70 11.70 10.52 9.99 9.51 Total Reserves 196.49 180.02 135.82 122.14 110.26 74.93 62.91 15.49 7.92 7.39 Non-Current Liabilities 0.21 0.66 6.04 7.84 3.58 1.42 1.73 3.95 4.87 6.74 Secured Loans 0.95 0.87 5.07 6.40 2.36 0.02 0.14 2.46 3.52 4.59 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.76 1.66 1.46 1.16 1.06 0.98 1.18 0.85 0.61 1.49 Current Liabilities 82.30 80.46 71.13 50.27 50.40 48.54 41.21 42.67 37.24 44.74 Trade Payables 37.97 45.51 41.74 29.58 31.96 30.57 21.80 22.31 18.76 26.52 Other Current Liabilities 10.70 7.21 5.03 4.99 5.59 0.78 0.87 4.81 3.20 2.54 Short Term Borrowings 28.64 23.31 19.27 10.93 7.62 11.61 14.24 14.09 14.76 15.56 Short Term Provisions 4.99 4.43 5.09 4.78 5.23 5.58 4.30 1.46 0.53 0.12 Total Liabilities 291.72 274.92 225.21 192.46 176.46 136.59 117.55 73.40 60.02 68.66 Net Block 91.10 92.36 92.48 89.64 33.69 24.38 25.34 19.05 19.10 19.84 Gross Block 135.86 130.12 124.26 115.66 57.74 46.58 45.78 37.66 35.79 34.94 Accumulated Depreciation 44.75 37.76 31.78 26.02 24.05 22.20 20.45 18.61 16.69 15.10 Non Current Assets 132.73 109.98 96.48 93.37 77.17 40.01 26.46 20.02 19.42 20.15 Capital Work in Progress 0.00 0.00 0.00 0.00 40.50 14.76 0.28 0.45 0.00 0.00 Non Current Investment 7.76 4.08 2.06 2.06 2.06 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.20 1.09 0.87 0.78 0.63 0.58 0.57 0.52 0.32 0.32 Other Non Current Assets 32.67 12.46 1.08 0.90 0.29 0.29 0.28 0.00 0.00 0.00 Current Assets 152.37 157.97 120.98 92.43 97.24 96.17 90.99 53.38 40.60 48.51 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.07 0.02 0.02 Inventories 59.33 45.06 27.01 5.20 16.96 15.26 14.23 13.79 11.14 13.46 Sundry Debtors 48.29 60.23 61.18 49.75 43.93 43.37 38.42 25.69 16.09 26.51 Cash & Bank 14.62 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29 Other Current Assets 30.14 2.58 20.28 22.95 34.12 29.01 15.60 10.87 10.63 6.21 Short Term Loans & Adv. 27.80 29.66 8.69 11.44 12.60 14.41 1.50 9.01 8.45 4.40 Net Current Assets 70.07 77.51 49.85 42.16 46.85 47.62 49.78 10.71 3.35 3.77 Total Assets 291.72 274.91 225.20 192.46 176.45 136.60 117.55 73.40 60.02 68.66

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 206.98 193.41 146.47 132.89 121.22 86.63 Share Capital 12.71 12.65 12.22 12.22 12.22 11.70 Total Reserves 194.27 178.16 134.25 120.67 109.00 74.93 Non-Current Liabilities 0.50 0.65 6.04 7.84 3.58 1.42 Secured Loans 1.26 0.87 5.07 6.40 2.36 0.02 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.76 1.66 1.46 1.16 1.06 0.98 Current Liabilities 84.56 82.57 72.69 53.27 56.48 48.54 Trade Payables 38.95 47.59 43.30 32.21 37.38 30.57 Other Current Liabilities 11.06 7.28 5.03 4.90 5.91 0.78 Short Term Borrowings 29.56 23.31 19.27 10.93 7.62 11.61 Short Term Provisions 4.99 4.39 5.09 5.23 5.57 5.58 Total Liabilities 292.04 276.63 225.20 194.00 181.28 136.59 Net Block 91.85 92.66 92.48 89.64 33.69 24.38 Gross Block 136.70 130.43 124.26 115.66 57.74 46.58 Accumulated Depreciation 44.85 37.77 31.78 26.02 24.05 22.20 Non Current Assets 125.74 106.22 94.42 91.31 75.11 40.01 Capital Work in Progress 0.00 0.00 0.00 0.00 40.50 14.76 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.22 1.11 0.87 0.78 0.63 0.58 Other Non Current Assets 32.67 12.46 1.08 0.90 0.29 0.29 Current Assets 159.59 163.36 123.04 96.03 104.13 96.17 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 59.38 45.06 27.01 5.20 16.96 15.26 Sundry Debtors 55.26 65.26 63.22 52.55 49.96 43.37 Cash & Bank 14.79 20.78 3.82 3.89 3.09 8.52 Other Current Assets 30.18 2.58 20.28 22.95 34.12 29.01 Short Term Loans & Adv. 27.84 29.69 8.69 11.44 12.60 14.41 Net Current Assets 75.04 80.79 50.35 42.76 47.65 47.62 Total Assets 292.03 276.64 225.20 194.00 181.28 136.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -0.25 -3.50 4.81 12.98 11.71 4.30 -5.45 3.59 6.21 -3.27 PBT 16.89 17.33 18.10 16.75 16.60 17.35 13.90 6.36 0.48 0.44 Adjustment 10.67 8.56 7.04 3.43 2.81 2.24 4.28 4.88 5.12 4.38 Changes in Working Capital -24.74 -32.52 -17.13 -2.74 -3.35 -11.29 -23.14 -7.65 0.61 -8.09 Cash after chg. in Working capital 2.82 -6.62 8.01 17.44 16.06 8.30 -4.95 3.59 6.21 -3.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.06 3.12 -3.20 -4.46 -4.35 -4.00 -0.50 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -8.71 -7.54 -8.47 -17.81 -39.35 -14.76 -7.99 -2.30 -1.05 0.12 Net Fixed Assets -5.74 -5.86 -8.60 -17.42 -36.90 -15.28 -7.95 -2.32 -0.85 -0.07 Net Investments -3.68 -2.02 0.00 0.00 -2.06 0.07 0.00 -0.05 0.00 0.00 Others 0.71 0.34 0.13 -0.39 -0.39 0.45 -0.04 0.07 -0.20 0.19 Cash from Financing Activity 3.14 27.67 4.39 5.68 21.36 -3.69 33.14 -1.04 -4.73 2.74 Net Cash Inflow / Outflow -5.82 16.63 0.73 0.85 -6.29 -14.15 19.70 0.25 0.42 -0.42 Opening Cash & Equivalents 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29 2.71 Closing Cash & Equivalent 14.62 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity -6.74 -6.29 4.11 12.77 12.80 4.30 PBT 13.08 17.05 18.09 16.39 17.98 17.35 Adjustment 10.77 8.56 7.04 3.43 2.81 2.24 Changes in Working Capital -27.52 -28.78 -17.82 -2.59 -3.64 -11.29 Cash after chg. in Working capital -3.68 -3.17 7.31 17.23 17.15 8.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.06 -3.12 -3.20 -4.46 -4.35 -4.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.56 -5.88 -8.47 -17.81 -37.29 -14.76 Net Fixed Assets -5.74 -5.86 -8.60 -17.42 -36.90 Net Investments -3.68 -2.02 0.00 0.00 -2.06 Others 3.86 2.00 0.13 -0.39 1.67 Cash from Financing Activity 6.31 29.13 4.30 5.84 19.06 -3.69 Net Cash Inflow / Outflow -5.99 16.95 -0.07 0.80 -5.43 -14.15 Opening Cash & Equivalents 20.78 3.82 3.89 3.09 8.52 22.66 Closing Cash & Equivalent 14.79 20.78 3.82 3.89 3.09 8.52

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 159.34 146.79 114.84 104.52 98.58 73.69 63.68 24.73 17.92 17.77 ROA 4.69% 6.00% 7.14% 6.77% 7.83% 9.46% 10.59% 7.74% 0.75% 0.66% ROE 6.85% 9.20% 11.12% 10.06% 11.86% 14.96% 20.12% 23.50% 2.76% 2.66% ROCE 10.13% 10.95% 12.82% 13.12% 15.26% 20.22% 24.91% 24.10% 11.36% 11.58% Fixed Asset Turnover 1.30 1.08 0.96 1.27 2.25 2.65 2.68 2.25 1.90 2.25 Receivable days 114.88 160.69 175.37 155.22 135.78 121.75 104.83 92.47 115.48 109.77 Inventory Days 110.51 95.39 50.92 36.72 50.11 43.90 45.82 55.17 66.68 61.53 Payable days 211.72 302.36 299.07 236.52 114.92 91.29 86.27 110.47 140.55 129.01 Cash Conversion Cycle 13.66 -46.28 -72.78 -44.58 70.96 74.36 64.38 37.17 41.61 42.30 Total Debt/Equity 0.15 0.14 0.18 0.15 0.10 0.14 0.19 0.68 1.14 1.23 Interest Cover 3.99 6.11 10.33 12.08 18.83 13.68 6.13 2.76 1.20 1.03

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 157.52 145.25 113.56 103.33 97.55 73.69 ROA 3.34% 5.87% 7.11% 6.46% 8.36% 8.80% ROE 4.94% 9.13% 11.25% 9.89% 12.94% 13.95% ROCE 8.46% 10.85% 12.94% 12.99% 16.54% 19.30% Fixed Asset Turnover 1.34 1.11 0.96 1.30 2.41 2.63 Receivable days 122.66 166.45 183.01 165.97 135.71 129.12 Inventory Days 106.29 93.37 50.92 35.88 46.85 45.43 Payable days 215.82 311.49 316.67 253.69 117.21 106.58 Cash Conversion Cycle 13.14 -51.67 -82.73 -51.84 65.35 67.97 Total Debt/Equity 0.16 0.14 0.19 0.15 0.10 0.14 Interest Cover 3.31 6.03 10.32 11.85 20.30 13.68

Top Investors:

pharmadanica a/s

ginnerup capital aps

investor education and protection fund (iepf)

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback